Clinical trials recruiting for Metastatic Microsatellite Stable Colorectal Carcinoma
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Abemaciclib | 1 |
| Fluorouracil | 1 |
| Nadunolimab | 1 |
| Temozolomide | 1 |
| Toripalimab | 1 |
| Tuvusertib | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 2 |
| New York | 2 |
| Pennsylvania | 2 |
| Connecticut | 1 |
| Illinois | 1 |
| Kansas | 1 |
| Maryland | 1 |
| Missouri | 1 |
| Ohio | 1 |
| Oklahoma | 1 |
| Tennessee | 1 |
Top cities
Self-screener
Recruiting trials
- Combination Immunotherapy for the Treatment of Chemotherapy-refractory Metastatic MSS CRC
- Testing the Addition of an Anti-Cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (5-Fluorouracil) for Metastatic, Refractory Colorectal Cancer
- Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness
Related conditions
Trials recruiting for Metastatic Microsatellite Stable Colorectal Carcinoma often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Metastatic Microsatellite Stable Colorectal Carcinoma trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.